At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Device (device)
- How long the study runs
- Study runs about 695 months (dates as stated)
- About the drug or intervention
- Device (device)
- Patient visit burden
- Not specified by the sponsor
In plain English
This study looks at the long-term reliability and performance of Medtronic cardiac devices that are already on the market, in people with heart rhythm problems such as arrhythmia, bradycardia, heart failure and sinus tachycardia. The sponsor is Medtronic.
Who can take part
- You (or your legal guardian) give written informed consent and permission for the study team to access and use your health information
- You are due to have a Medtronic device implanted, or had one implanted within the last 30 days, for pacing, sensing or defibrillation
- OR you took part in an earlier qualifying study (an IDE study) of a Medtronic device, with complete implant and follow-up data, and you agree to release that data
Who may not be able to
- You cannot be reached for follow-up appointments
- You are excluded under local law (in EMEA regions only)
- You had a Medtronic device implanted at a hospital not taking part in the study, and your implant details and current status cannot be confirmed within 30 days of the implant
- The study has already filled its set limit of participants for that particular Medtronic device
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team about visits, how long the study lasts and what taking part involves.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 20,000
- Started
- 1983-01
- Last checked
- 2026-08
Plain English Summary
What is this study?
- • Testing a new treatment for arrhythmia
- • Clinical study - 20,000 participants
- • The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities
Who can take part?
- • Adults
- • Diagnosed with arrhythmia
Where?
- • Birmingham
- • Blackpool
- • Bristol
- • Leeds
- • +9 more UK sites
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
More detail
All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
Treatment history
Treatments you must have had:
- ✓ by an institution's IRB/MEC/REB
What the study is looking for
- ✓Subject or appropriate legal guardians provide written agreement to take part and/or authorization for access to and use...
- ✓AND one of the following must also apply:
- ✓Subject is indicated for implant or within 30 days post-implant of at least one Medtronic market-released product...
Who cannot take part
- ✗Subjects who are, or will be inaccessible for follow-up
- ✗Subjects with exclusion criteria required by local law (EMEA only)
- ✗Subjects receiving an implant of a Medtronic device at a non-participating center and the implant data and current...
- ✗Subjects implanted with a Medtronic device whose predetermined enrollment limit for that specific product has been...
See the full criteria
Where Is This Study? (13 UK sites)
Birmingham, United Kingdom
Blackpool, United Kingdom
Bristol, United Kingdom
Leeds, United Kingdom
Leicester, United Kingdom
Liverpool, United Kingdom
London, United Kingdom
Manchester, United Kingdom
Middlesbrough, United Kingdom
Northampton, United Kingdom
Nottingham, United Kingdom
Sheffield, United Kingdom
Southampton, United Kingdom
How to Get in Touch
Medtronic CRM Clinical Trials
Sponsor contactCONTACT